Author:
Devillier P.,Naline E.,Dubus J.-C.
Subject
Pulmonary and Respiratory Medicine
Reference65 articles.
1. Newman SP : Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs ? Br J Clin Pharmacol 2000 ; 49 : 529-37.
2. Weda M, Zanen P, de Boer AH, Barends DM, Frijlink HW : The therapeutic index of locally acting drugs as a function of their fine particle mass and particle size distribution – a literature review. Curr Drug Deliv 2008 ; 5 : 142-7.
3. Guidance for industry – Nasal Spray and inhalation solution, suspension and spray drug products – chemistry, manufacturing, and controls documentation. CDER, US department of Health and Human Services, Food and Drug Administration, 2002.
4. Guidelines on the requirements for clinical documentation for orally inhaled products including the requirements for demonstration of therapeutic equivalence between two inhaled products for use in the treatment of asthma and chronic obstructive pulmonary disease. CPMP/EWP/4151/00. October 2007.
5. De boer AH, Gjaltema D, Hagedoorn P, Frijlink HW : Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique. Int J Pharmaceutics 2002 ; 49 : 219-31.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献